100% of 5 Star-rated Medicare Advantage Prescription Drug Plans Partner with SPH Analytics
SPH Analytics, the top ranked member experience measurement firm in the health plan market, announced today that all 21 Medicare Advantage Prescription Drug (MA-PD) health plans receiving the highest 5 Star Rating in the 2021 Part C and D Star ratings are SPH clients, according to reports recently released by the Centers for Medicare and Medicaid Services (CMS).
“We salute the 2021 five Star plans, and we are honored to partner with each one of these plans who are clearly driving the strongest member satisfaction and engagement and the best access to care,” said Amy Amick, President and CEO of SPH Analytics. “Not only did thirteen of our clients maintain their top-of-the-line 5 Star Ratings from the previous year, eight additional plans improved from a 4.5 Star rating last year to the 5 Star pinnacle this year. It’s a remarkable accomplishment in the most challenging year imaginable. We offer our appreciation and congratulations to these health plan clients on a job well done.”